A case of gastrointestinal stromal tumor with liver and bone metastases effectively treated with radiofrequency ablation and imatinib mesylate
作者： Tatsuro Shimokama , Shinji Hirai , Yuji Oka , Akihisa Ishikawa , Satoshi Ono
DOI: 10.11405/NISSHOSHI.103.1274
关键词: Medicine 、 Stromal tumor 、 Radiofrequency ablation 、 Metastasis 、 GiST 、 Imatinib mesylate 、 General surgery 、 Radiology 、 Perforation (oil well) 、 Small intestine 、 Performance status
摘要: A 58-year-old man was admitted because of perforation the small intestine by a gastrointestinal stromal tumor (GIST). First, including GIST resected; and then 2 month later, part liver (S5) conforming to metastatic lesion surgically removed. Twelve months another metastases found, surgical treatment recommended; but patient requested non-surgical therapy, so radiofrequency ablation (RFA) successfully performed. After that, recurrence metastasis not observed, observed on fifth lumbar vertebra; administration imatinib mesylate started. 28 after initial still invisible, bone had grown. The is alive with good performance status. This report shows that multi-modality therapy surgery, RFA effective for GIST.
sci-hub.st 参考文章(12)
L. Buscarini, F. Fornari, S. Rossi, Interstitial Radiofrequency Hyperthermia in the Treatment of Small Hepatocellular Carcinoma: Percutaneous US-Guidance of Electrode Needle Ultraschalldiagnostik ’91. ,vol. 91, pp. 218- 222 ,(1992) , 10.1007/978-3-642-47607-5_40
Ronald P. DeMatteo, George D. Demetri, Margaret von Mehren, Burton L. Eisenberg, Brian P. Rubin, Robert G. Maki, Christopher D.M. Fletcher, Robert Benjamin, Haesun Choi, Charles D. Blanke, Gist Task Force Nccn Gist Task Force, Chris Corless, Annick D. Van den Abbeele, NCCN Task Force Report : Optimal management of patients with gastrointestinal stromal tumor (GIST)-expansion and update of NCCN clinical practice guidelines Journal of The National Comprehensive Cancer Network. ,vol. 2, pp. 30- ,(2004)
Eng-Hen Ng, Raphael E. Pollock, Marvin M. Romsdahl, Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer. ,vol. 69, pp. 1334- 1341 ,(1992) , 10.1002/1097-0142(19920315)69:6<1334::AID-CNCR2820690606>3.0.CO;2-S
Luigi Solbiati, Tito Livraghi, S. Nahum Goldberg, Tiziana Ierace, Franca Meloni, Marina Dellanoce, Luca Cova, Elkan F. Halpern, G. Scott Gazelle, Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. ,vol. 221, pp. 159- 166 ,(2001) , 10.1148/RADIOL.2211001624
Christopher D.M. Fletcher, Heikki Joensuu, George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg, Peter J. Roberts, Michael C. Heinrich, David A. Tuveson, Samuel Singer, Milos Janicek, Jonathan A. Fletcher, Stuart G. Silverman, Sandra L. Silberman, Renaud Capdeville, Beate Kiese, Bin Peng, Sasa Dimitrijevic, Brian J. Druker, Christopher Corless, Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England Journal of Medicine. ,vol. 347, pp. 472- 480 ,(2002) , 10.1056/NEJMOA020461
Michael Y. M. Chen, Robert E. Bechtold, Paul D. Savage, Cystic Changes in Hepatic Metastases from Gastrointestinal Stromal Tumors (GISTs) Treated with Gleevec (Imatinib Mesylate) American Journal of Roentgenology. ,vol. 179, pp. 1059- 1062 ,(2002) , 10.2214/AJR.179.4.1791059
J. Verweij, H.T. Mouridsen, O.S. Nielssen, P.J. Woll, R. Somers, A.T. van Oosterom, M. Van Glabbeke, T. Tursz, The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view. Critical Reviews in Oncology Hematology. ,vol. 20, pp. 193- 201 ,(1995) , 10.1016/1040-8428(94)00146-K
T Livraghi, C Vettori, S Lazzaroni, Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology. ,vol. 179, pp. 709- 712 ,(1991) , 10.1148/RADIOLOGY.179.3.2027979
S. Stroobants, J. Goeminne, M. Seegers, S. Dimitrijevic, P. Dupont, J. Nuyts, M. Martens, B. van den Borne, P. Cole, R. Sciot, H. Dumez, S. Silberman, L. Mortelmans, A. van Oosterom, 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). European Journal of Cancer. ,vol. 39, pp. 2012- 2020 ,(2003) , 10.1016/S0959-8049(03)00073-X
S Rossi, M Di Stasi, E Buscarini, P Quaretti, F Garbagnati, L Squassante, C T Paties, D E Silverman, L Buscarini, Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. American Journal of Roentgenology. ,vol. 167, pp. 759- 768 ,(1996) , 10.2214/AJR.167.3.8751696